1. Home
  2. VAC vs STOK Comparison

VAC vs STOK Comparison

Compare VAC & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marriott Vacations Worldwide Corporation

VAC

Marriott Vacations Worldwide Corporation

N/A

Current Price

$70.22

Market Cap

2.0B

Sector

Finance

ML Signal

N/A

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

N/A

Current Price

$32.06

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VAC
STOK
Founded
1984
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2011
2019

Fundamental Metrics

Financial Performance
Metric
VAC
STOK
Price
$70.22
$32.06
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$75.38
$39.20
AVG Volume (30 Days)
650.5K
699.1K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
4.71%
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
$5,032,000,000.00
$184,420,000.00
Revenue This Year
$54.41
N/A
Revenue Next Year
$2.06
$82.05
P/E Ratio
N/A
N/A
Revenue Growth
1.31
404.50
52 Week Low
$44.58
$5.35
52 Week High
$86.33
$40.22

Technical Indicators

Market Signals
Indicator
VAC
STOK
Relative Strength Index (RSI) 60.45 43.79
Support Level $63.77 $31.60
Resistance Level $73.13 $35.75
Average True Range (ATR) 2.63 2.35
MACD -0.01 -0.51
Stochastic Oscillator 71.95 21.03

Price Performance

Historical Comparison
VAC
STOK

About VAC Marriott Vacations Worldwide Corporation

Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: